RxDoctor Payments Data

Perry Kuhn, PA

Physician Assistant · Lakeland, FLNPI 1548666126

Payments from drug & device makers

$4,700in general payments, 2019–2025

Across 250 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$609
  • Pfizer$387
  • Bayer$325
  • Boehringer Ingelheim$291
  • Phathom Pharmaceuticals, Inc.$278
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,66199%
  • Education$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,700 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$60,375
Medicare patients
211
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide139$160,035
MounjaroTirzepatide131$144,707
WegovySemaglutide15$19,650
JardianceEmpagliflozin14$9,412
Ibandronate Sodium15$842
Metformin Hcl ErMetformin Hcl97$562
Topiramate104$511
Rosuvastatin Calcium16$332
Amlodipine Besylate51$312
Escitalopram Oxalate13$213
Losartan Potassium25$195
Atorvastatin Calcium24$164
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide13$159
Levothyroxine Sodium30$142
Famotidine12$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$1,132$179,685154 claims
Lilly USA, LLCMounjaro$609$144,707131 claims
Boehringer IngelheimJardiance$291$9,41214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →